Clinical Trials Browser

Phase 2 × Uveal Melanoma × flt3 ligand protein × Clear all

NCT02129075 2021-11-16

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

Phase 2 Completed

60 enrolled 13 charts

Uveal Melanoma, Melanoma